Deal Spree Continues as Celgene Nabs Juno in $9B Deal Post author:Sam Post published:January 21, 2018 Post category:BioPharma The announcement sent shares of Juno soaring more than 27 percent in pre-market trading to $86.26. Source: BioSpace You Might Also Like Fully Loaded With Nearly 500 Employees in Rockville, GlaxoSmithKline Chief Lays Out 2018 Goals December 7, 2017 DxTerity Collaborates With On The Development Of A Cancer Genomic Blood Test To Predict Response To Radiation Therapy September 21, 2017 Inventiva Announces First-Half 2017 Financial And Corporate Update July 5, 2017
Fully Loaded With Nearly 500 Employees in Rockville, GlaxoSmithKline Chief Lays Out 2018 Goals December 7, 2017
DxTerity Collaborates With On The Development Of A Cancer Genomic Blood Test To Predict Response To Radiation Therapy September 21, 2017